| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M SELEXIPAG (is an active metabolite)
| SELEXIPAG | BLOOD | - | Tmax 3.5 HOUR PPB 99 PERCENT HT 9.8 HOUR | IP PROSTACYCLIN RECEPTOR | GPCR PI2R_HUMAN AGONIST P43119 | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| SELEXIPAG (has an active metabolite)
| SELEXIPAG | BLOOD | ORAL INTRAVENOUS | Tmax 2 HOUR PPB 99 PERCENT Cl 35 LITER / HOUR HT 1.65 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | IP PROSTACYCLIN RECEPTOR | GPCR PI2R_HUMAN AGONIST P43119 | EMA | |||
